Skip to main content
. 2018 Oct 11;18:964. doi: 10.1186/s12885-018-4873-9

Fig. 3.

Fig. 3

Magnetic resonance imaging. Gadolinium-contrast-enhanced T1-weighted 3D magnetic resonance imaging of the brain after radiotherapy (a), before afatinib treatment (b), and after 4 weeks (c) and 8 weeks (d) of afatinib treatment. The lesion is indicated by an arrow